Accessibility: Skip TopNav
Table
Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study
Format
PNG
Quelle:
Akari Therapeutics Plc
Downloads
Originalgröße
Groß
Mittel
Klein